Patients who received MRI-guided focused ultrasound during standard-of-care chemotherapy had an almost 40% increase in overall survival, according to a study published Nov. 24 in the Lancet Oncology. Led by a team from Baltimore-based University of Maryland School of Medicine,…
The Latest
An AI-enabled lung nodule management program facilitated an 87% follow-up of nodules identified during CT scans, according to a study published Oct. 23 in the Journal of Thoracic Oncology. Researchers at Rochester, Minn.-based Mayo Clinic used natural language processing software…
The University of Chicago Medicine has launched a center dedicated to rare blood cancers. Led by UChicago Medicine hematologist/oncologist Michael Drazer, MD, PhD, as director, the Miller Family Center for Rare Blood Cancers began operations in July, according to a…
Providence, based in Renton, Wash., Microsoft Research and the University of Washington have developed an AI pathology model that researchers say can map how immune cells interact with tumors on a scale not previously possible. The model, called GigaTIME, was…
New York City-based NYU Langone Hospital-Brooklyn has tapped Jennifer Nishimura, MD, to serve as the hospital’s first chief of thoracic surgery. She will also serve as a clinical assistant professor in the department of cardiothoracic surgery at NYU Grossman School…
According to the American Lung Association’s 2025 “State of Lung Cancer” report, just 18.2% of eligible individuals are screened for lung cancer nationwide, a rate almost three times lower than colorectal and breast cancer screening rates. Compounding this challenge, a…
The National Comprehensive Cancer Network has named Renuka Iyer, MD, as chief medical officer. Dr. Iyer currently serves as section chief of gastrointestinal oncology and vice chair of faculty affairs at Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center, according to…
One dose of an HPV vaccine was found to be “noninferior” to two doses, according to a study published Dec. 3 in The New England Journal of Medicine. More than 20,000 participants enrolled in the randomized study of two HPV…
At The University of Texas MD Anderson Cancer Center, our mission has always been clear: to end cancer. Achieving this goal requires more than just groundbreaking research and exceptional patient care — it requires collaboration. Toward this aim, we have…
The FDA approved a new indication for Breyanzi on Dec. 4, making it the first CAR T-cell therapy in the U.S. for adults with marginal zone lymphoma who have relapsed or failed treatment after at least two prior lines of…